歡迎蒞臨南京沃博生物科技有限公司官方網(wǎng)站!

Triciribine phosphate (TCN-P,VQD-002,NSC-280594) 磷酸曲西立濱

貨號 IPA1014 售價(元) 3618
規(guī)格 5mg CAS號 61966-08-3
  • 產(chǎn)品簡介
  • 相關(guān)產(chǎn)品

貨號

名稱

規(guī)格

價格

IPA1014-0005MG

Triciribine phosphate

5MG

3618

IPA1014-0010MG

Triciribine phosphate

10MG

6623

產(chǎn)品簡介:

   磷酸曲西立濱是一種蛋白激酶B抑制劑。它有可能用于治療卵巢癌和乳腺癌。

產(chǎn)品性質(zhì):

CAS No.:61966-08-3

別名:VQD 002, PTX200, VQD002, PTX 200, PTX-200, VQD-002

分子量:400.28

分子式:C13H17N6O7P

存儲:Powder: -20°C for 3 years | In solvent: -80°C for 2 years

溶解度:DMSO: Soluble( < 1 mg/mL refers to the product slightly soluble or insoluble )

注意事項:

為了您的安全和健康,請穿實驗服并戴一次性手套操作。

Reference:

1. Garrett CR, Coppola D, Wenham RM, Cubitt CL, Neuger AM, Frost TJ, Lush RM, Sullivan DM, Cheng JQ, Sebti SM. Phase I pharmacokinetic and pharmacodynamic study of triciribine phosphate monohydrate, a small-molecule inhibitor of AKT phosphorylation, in adult subjects with solid tumors containing activated AKT. Invest New Drugs. 2011 Dec;29(6):1381-9. doi: 10.1007/s10637-010-9479-2. PubMed PMID: 20644979; PubMed Central PMCID: PMC4612514.

2. Kim R, Yamauchi T, Husain K, Sebti S, Malafa M. Triciribine Phosphate Monohydrate, an AKT Inhibitor, Enhances Gemcitabine Activity in Pancreatic Cancer Cells. Anticancer Res. 2015 Sep;35(9):4599-604. PubMed PMID: 26254348.

3. Sampath D, Malik A, Plunkett W, Nowak B, Williams B, Burton M, Verstovsek S, Faderl S, Garcia-Manero G, List AF, Sebti S, Kantarjian HM, Ravandi F, Lancet JE. Phase I clinical, pharmacokinetic, and pharmacodynamic study of the Akt-inhibitor triciribine phosphate monohydrate in patients with advanced hematologic malignancies. Leuk Res. 2013 Nov;37(11):1461-7. doi: 10.1016/j.leukres.2013.07.034. PubMed PMID: 23993427; PubMed Central PMCID: PMC4205589.

4. Moore EC, Hurlbert RB, Boss GR, Massia SP. Inhibition of two enzymes in de novo purine nucleotide synthesis by triciribine phosphate (TCN-P). Biochem Pharmacol. 1989 Nov 15;38(22):4045-51. PubMed PMID: 2480792.